DEVELOPING TRUSTWORTHY ARTIFICIAL INTELLIGENCE (AI)-DRIVEN TOOLS TO PREDICT VASCULAR DISEASE RISK AND PROGRESSION

Informazioni relative al progetto

VASCUL-AID

ID dell’accordo di sovvenzione: 101080947

DOI

10.3030/101080947

Data della firma CE 24 Aprile 2023

Data di avvio 1 Maggio 2023

Data di completamento 30 Aprile 2029

Finanziato da

• Health

Costo totale

€ 5 969 125,00

Contributo UE

€ 5 969 125,00

Coordinato da

STICHTING AMSTERDAM UMC
Netherlands

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Documents, reports (8)

Submission package RETRO-VASCULAID-AAA clinical DATA study

Submission package RETRO-VASCULAID-AAA clinical DATA study (ethical approval, final study protocol, registry nr) prior to first enrolment.RETRO-VASCULAID-AAA clinical DATA study: retrospective data collection of 5000 patients at clinical partners (Annex Clinical Studies).

Protocol and SOPs for collection of data for each data type

Protocol and SOPs for collection of data (medical images and pathological analysis) for each data type

A functional design describing the architecture and data flows that will be forming the apps

A functional design describing the architectureand data flows that will be forming the apps will be delivered.

Submission package PRO-VASCULAID-AAA clinical DATA study

Submission package PRO-VASCULAID-AAA clinical DATA study (ethical approval, final study protocol, registry nr, national authorities) prior to first enrolment.PRO-VASCULAID-AAA clinical DATA study: prospective data collection of 350 patients (phase I) at clinical partners (Annex Clinical Studies).

Submission package RETRO-VASCULAID-PAD clinical DATA study

Submission package RETRO-VASCULAID-PAD clinical DATA study (ethical approval, final study protocol, registry nr) prior to first enrolment.RETRO-VASCULAID-PAD clinical DATA study: retrospective data collection of 6000 patients at clinical partners (Annex Clinical Studies).

Standardised set of parameters to evaluate data outcome measurements

Standardised set of parameters defined to evaluate the data outcome measurements.

Project management handbook, month 1

Periodic reports with templates (no deliverable) as instructed by the PO.

Submission package PRO-VASCULAID-PAD clinical DATA study

Submission package PRO-VASCULAID-PAD clinical DATA study (ethical approval, final study protocol, registry nr, national authorities) prior to first enrolment.PRO-VASCULAID-PAD clinical DATA study: prospective data collection of 420 patients (phase I) at clinical partners (Annex Clinical Studies).

Other (5)

HELSI AI framework updates (M12)
Trustworthy AI in healthcare procedures: guidelines (M12)
A secure and redundant SaaS platform to host the apps

A secure and redundant SaaS platform to hostthe apps is established.

PAA segmentation algorithm established
Aorta segmentation algorithm established

Data Management Plan (1)

Data management plan

Ethics Requirements (1)

AI - OEI - Requirement No. 1

Ethics report of External Ethics Advisor:Due to sensitivity of the use of AI as a decision-making tool, an External Independent Ethics Advisor must be appointed to support the beneficiaries to identify the ethical concerns. An ethics report by the ethics advisor must be submitted at M3 with a view to the first ethics check. Details must be provided regarding AI decision-making support tool, and notably on human agency aspects of the involved clinicians. European Commission guidelines on AI can be found at the following link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/ethics-by-design-and-ethics-of-use-approaches-for-artificial-intelligence_he_en.pdf The European Commission Guidance for Ethics Advisors/Boards can be found in the FTOP at the following link: https://ec.europa.eu/info/funding-tenders/opportunities/docs/2021-2027/horizon/guidance/roles-and-functions-of-ethics-advisory-ethics-advisory-boards-in-ec-funded-projects_he_en.pdf.

Websites, patent fillings, videos etc. (3)

Communication, Dissemination and Exploitation plan
Website VASCUL-AID online
Social media accounts online

Pubblicazioni

Peer reviewed articles (3)

Global Control for Local SO(3)-Equivariant Scale-Invariant Vessel Segmentation

Autori: Patryk Rygiel, Dieuwertje Alblas, Christoph Brune, Kak Khee Yeung, Jelmer M. Wolterink
Pubblicato in: arXiv Computer Vision and Pattern Recognition, Numero 2024.15314, 2024, ISSN 2331-8422
Editore: arXiv Computer Vision and Pattern Recognition
DOI: 10.48550/arXiv.2403.15314

International Consensus on Core Outcomes in Vascular Surgery: A Delphi Study Protocol

Autori: Sabrina Zwetsloot, Lotte Rijken, Stefan Smorenburg, Venkat Ayyalasomayajula, Vincent Jongkind, Kak Khee Yeung
Pubblicato in: SSRN, Numero 4947551, 2024, ISSN 1556-5068
Editore: SSRN
DOI: 10.2139/ssrn.4947551

SIRE: scale-invariant, rotation-equivariant estimation of artery orientations using graph neural networks

Autori: Dieuwertje Alblas, Julian Suk, Christoph Brune, Kak Khee Yeung, Jelmer M. Wolterink
Pubblicato in: arXiv Computer Vision and Pattern Recognition, Numero 2311.05400, 2023, ISSN 2331-8422
Editore: arXiv
DOI: 10.48550/arXiv.2311.05400

Book chapters (1)

Implicit Neural Representations for Modeling of Abdominal Aortic Aneurysm Progression

Autori: Dieuwertje Alblas, Marieke Hofman, Christoph Brune, Kak Khee Yeung, Jelmer M. Wolterink
Pubblicato in: Lecture Notes in Computer Science, Functional Imaging and Modeling of the Heart, 2023, ISSN 1611-3349
Editore: Springer Nature Switzerland
DOI: 10.1007/978-3-031-35302-4_37